Leukine and Pneumonia aggravated - a phase IV clinical study of FDA data

Summary:

Pneumonia aggravated is reported as a side effect among people who take Leukine (sargramostim), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Acyclovir, and have Malignant melanoma.

The phase IV clinical study analyzes which people have Pneumonia aggravated when taking Leukine. It is created by eHealthMe based on reports of 2,173 people who have side effects when taking Leukine from the FDA, and is updated regularly.

What is Leukine?

Leukine has active ingredients of sargramostim. eHealthMe is studying from 2,188 Leukine users. Check the latest studies of Leukine.

What is Pneumonia aggravated?

Pneumonia aggravated is found to be associated with 2,236 drugs and 885 conditions by eHealthMe. Check the latest studies of Pneumonia aggravated.

On Aug, 01, 2026

2,173 people reported to have side effects when taking Leukine.
Among them, 58 people (2.67%) have Pneumonia aggravated.

Could Leukine cause Pneumonia aggravated?

Among these 58 people:

How long have people been on Leukine when they have Pneumonia aggravated? *

What is the gender of people who have Pneumonia aggravated when taking Leukine? *

female: 40.38 %
male: 59.62 %

What is the age of people who have Pneumonia aggravated when taking Leukine? *

What are other drugs people take besides Leukine? *

What are other side effects people have besides Pneumonia aggravated? *

Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 10 people, 17.24%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 10 people, 17.24%
Sepsis (a severe blood infection that can lead to organ failure and death): 10 people, 17.24%
Dehydration (dryness resulting from the removal of water): 10 people, 17.24%
Dyspnea (difficult or laboured breathing): 10 people, 17.24%
Hypotension (abnormally low blood pressure): 9 people, 15.52%
Febrile Neutropenia (fever with reduced white blood cells): 8 people, 13.79%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 8 people, 13.79%
Pain: 8 people, 13.79%
Infection: 7 people, 12.07%

What are the existing conditions these people have? *

Malignant Melanoma (skin cancer rises from melancytes): 7 people, 12.07%
Multiple Myeloma (cancer of the plasma cells): 5 people, 8.62%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 8.62%
Metastases To Bone (cancer spreads to bone): 5 people, 8.62%
Nausea And Vomiting: 4 people, 6.90%
White Blood Cell Count Decreased: 3 people, 5.17%
Abdominal Pain: 3 people, 5.17%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 5.17%
Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 3 people, 5.17%
Chills (felling of cold): 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Leukine and have Pneumonia aggravated?

- Check whether Pneumonia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Leukine:

Leukine (2,188 reports)

Browse all side effects of Leukine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumonia aggravated:

Pneumonia aggravated (2,236 drugs)

Browse all the conditions that are associated with Pneumonia aggravated:

Pneumonia aggravated (885 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sargramostim (the active ingredients of Leukine) and Leukine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.